These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 32403071

  • 1. Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation.
    Nemieboka B, Sharma SK, Rao TD, Edwards KJ, Yan S, Wang P, Ragupathi A, Piersigilli A, Spriggs DR, Lewis JS.
    Nucl Med Biol; 2020; 86-87():9-19. PubMed ID: 32403071
    [Abstract] [Full Text] [Related]

  • 2. Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.
    Sharma SK, Sevak KK, Monette S, Carlin SD, Knight JC, Wuest FR, Sala E, Zeglis BM, Lewis JS.
    J Nucl Med; 2016 May; 57(5):771-6. PubMed ID: 26837339
    [Abstract] [Full Text] [Related]

  • 3. Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.
    Dharma Rao T, Park KJ, Smith-Jones P, Iasonos A, Linkov I, Soslow RA, Spriggs DR.
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):462-72. PubMed ID: 20453816
    [Abstract] [Full Text] [Related]

  • 4. ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody.
    Sharma SK, Mack KN, Piersigilli A, Pourat J, Edwards KJ, Keinänen O, Jiao MS, Zhao H, White B, Brooks CL, de Stanchina E, Madiyalakan MR, Hollingsworth MA, Radhakrishnan P, Lewis JS, Zeglis BM.
    Clin Cancer Res; 2022 Mar 01; 28(5):948-959. PubMed ID: 34907079
    [Abstract] [Full Text] [Related]

  • 5. Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer.
    Mack KN, Samuels ZV, Carter LM, Viray TD, Mandleywala K, Brooks CL, Hollingsworth MA, Radhakrishnan P, Lewis JS.
    J Nucl Med; 2024 Apr 01; 65(4):580-585. PubMed ID: 38485271
    [Abstract] [Full Text] [Related]

  • 6. Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer.
    Aithal A, Junker WM, Kshirsagar P, Das S, Kaur S, Orzechowski C, Gautam SK, Jahan R, Sheinin YM, Lakshmanan I, Ponnusamy MP, Batra SK, Jain M.
    PLoS One; 2018 Apr 01; 13(4):e0193907. PubMed ID: 29708979
    [Abstract] [Full Text] [Related]

  • 7. Generation and characterization of a monoclonal antibody to the cytoplasmic tail of MUC16.
    Gipson IK, Mandel U, Menon B, Michaud S, Tisdale A, Campos D, Clausen H.
    Glycobiology; 2017 Oct 01; 27(10):920-926. PubMed ID: 28673046
    [Abstract] [Full Text] [Related]

  • 8. Structural basis for antibody recognition of the proximal MUC16 ectodomain.
    Lee K, Perry K, Xu M, Veillard I, Kumar R, Rao TD, Rueda BR, Spriggs DR, Yeku OO.
    J Ovarian Res; 2024 Feb 19; 17(1):41. PubMed ID: 38374055
    [Abstract] [Full Text] [Related]

  • 9. Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.
    Rao TD, Tian H, Ma X, Yan X, Thapi S, Schultz N, Rosales N, Monette S, Wang A, Hyman DM, Levine DA, Solit D, Spriggs DR.
    PLoS One; 2015 Feb 19; 10(5):e0126633. PubMed ID: 25965947
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.
    Felder M, Kapur A, Gonzalez-Bosquet J, Horibata S, Heintz J, Albrecht R, Fass L, Kaur J, Hu K, Shojaei H, Whelan RJ, Patankar MS.
    Mol Cancer; 2014 May 29; 13():129. PubMed ID: 24886523
    [Abstract] [Full Text] [Related]

  • 12. Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models.
    Chen Y, Clark S, Wong T, Chen Y, Chen Y, Dennis MS, Luis E, Zhong F, Bheddah S, Koeppen H, Gogineni A, Ross S, Polakis P, Mallet W.
    Cancer Res; 2007 May 15; 67(10):4924-32. PubMed ID: 17510422
    [Abstract] [Full Text] [Related]

  • 13. Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies.
    Tu HF, Wong M, Tseng SH, Ingavat N, Olczak P, Notarte KI, Hung CF, Roden RBS.
    J Ovarian Res; 2024 Jan 16; 17(1):19. PubMed ID: 38225646
    [Abstract] [Full Text] [Related]

  • 14. Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth.
    Rao TD, Fernández-Tejada A, Axelrod A, Rosales N, Yan X, Thapi S, Wang A, Park KJ, Nemieboka B, Xiang J, Lewis JS, Olvera N, Levine DA, Danishefsky SJ, Spriggs DR.
    ACS Chem Biol; 2017 Aug 18; 12(8):2085-2096. PubMed ID: 28617578
    [Abstract] [Full Text] [Related]

  • 15. A novel monoclonal antibody to a defined peptide epitope in MUC16.
    Marcos-Silva L, Ricardo S, Chen K, Blixt O, Arigi E, Pereira D, Høgdall E, Mandel U, Bennett EP, Vakhrushev SY, David L, Clausen H.
    Glycobiology; 2015 Nov 18; 25(11):1172-82. PubMed ID: 26201951
    [Abstract] [Full Text] [Related]

  • 16. Application of a novel microscopic technique for quantifying CA125 binding to circulating mononuclear cells in longitudinal specimens during treatment for ovarian cancer.
    Lakatos K, González G, Hoballah J, Brooker J, Jeong S, Evans C, Krauledat P, Hansen WP, Elias KM, Patankar M, Fülöp V, Konstantinopoulos PA, Cramer DW.
    J Ovarian Res; 2022 Feb 26; 15(1):28. PubMed ID: 35219339
    [Abstract] [Full Text] [Related]

  • 17. Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer.
    Liu JF, Moore KN, Birrer MJ, Berlin S, Matulonis UA, Infante JR, Wolpin B, Poon KA, Firestein R, Xu J, Kahn R, Wang Y, Wood K, Darbonne WC, Lackner MR, Kelley SK, Lu X, Choi YJ, Maslyar D, Humke EW, Burris HA.
    Ann Oncol; 2016 Nov 26; 27(11):2124-2130. PubMed ID: 27793850
    [Abstract] [Full Text] [Related]

  • 18. A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer.
    Crawford A, Haber L, Kelly MP, Vazzana K, Canova L, Ram P, Pawashe A, Finney J, Jalal S, Chiu D, Colleton CA, Garnova E, Makonnen S, Hickey C, Krueger P, DelFino F, Potocky T, Kuhnert J, Godin S, Retter MW, Duramad P, MacDonald D, Olson WC, Fairhurst J, Huang T, Martin J, Lin JC, Smith E, Thurston G, Kirshner JR.
    Sci Transl Med; 2019 Jun 19; 11(497):. PubMed ID: 31217340
    [Abstract] [Full Text] [Related]

  • 19. A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing.
    Wang CW, Weaver SD, Boonpattrawong N, Schuster-Little N, Patankar M, Whelan RJ.
    Cancer Res Commun; 2024 Jan 31; 4(1):253-263. PubMed ID: 38197671
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.